UBS Group’s Thrive Acquisition Corporation Class A ordinary shares THAC Stock Holding History

UBS Group’s Portfolio THAC Stock Details THAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-650	Closed	-$6.7K	–	11464
2022 Q4	$6.7K	Buy	+650	New	+$6.65K	﹤0.01%	9000

UBS Group's THAC Position: Q1 2023 in Review

UBS Group sold out of Thrive Acquisition Corporation Class A ordinary shares (THAC) in Q1 2023, closing a stake of 650 shares — an estimated $6.7K sold.

UBS Group first reported a position in THAC in Q4 2022 and held it in 1 quarter. The position peaked at $6.7K in Q4 2022. 0 funds tracked by Wall St. Rank hold THAC as of Q1 2023.

UBS Group reported no remaining Thrive Acquisition Corporation Class A ordinary shares position as of Q1 2023 after selling out during the quarter.
UBS Group sold 650 Thrive Acquisition Corporation Class A ordinary shares shares in Q1 2023, an estimated $6.7K.
UBS Group first reported a position in Thrive Acquisition Corporation Class A ordinary shares in Q4 2022 and held it in 1 quarter.
UBS Group's Thrive Acquisition Corporation Class A ordinary shares position peaked at $6.7K in Q4 2022.
0 funds tracked by Wall St. Rank held Thrive Acquisition Corporation Class A ordinary shares as of Q1 2023.

Based on UBS Group's 13F filing for Q1 2023, filed 12 May 2023.